Open Access Microbiology
Meet our newest Editor-in-Chief
Kevin Tyler runs a cosmopolitan, multidisciplinary group taking a genomics led approach to tackling problems associated with a variety of (water borne and vector borne) microbial diseases supported by grants from the Wellcome Trust, the European Commission (Framework VI, VII, Horizon 2020 and Interreg) and the British Council for networks of research and collaboration across Europe, South America and Africa. He has served as an NTD expert to the European Commission and is an advocate for solutions to these diseases through his current role as the general secretary of the British Society for Parasitology.
His interest is focused at achieving an understanding of pathogen virulence - how and why new virulent lineages emerge and why some are profoundly affected by an infection which can be asymptomatic in others. His approach has been to utilize discoveries of specific pathogen biology and genetics from his laboratory to inform innovation and validation of novel diagnostics and therapeutics and public health approaches to tackling the diseases.
He has also been a proponent and pioneer of Open Access Publication and is a modernizer of effective communication and publication for research in communicable disease to enable access of the key scientific literature by scientists and clinicians in the more impoverished countries most affected by infectious disease. At the turn of the millennium he organized a series of internet conferences where scientists world-wide shared their work live, online and for free, guest Editing those articles for (perhaps) the first ever “open access” special issue of a traditional publication. He was Founder Editor of one of the first open access journals in infectious disease – (Kinetoplastid Biology and Disease), and was subsequently founder and Editor of the premier parasitology journal Parasites and Vectors and its popular Bugbitten community blog. He is currently Editor-in-Chief of Virulence.
Submit your questions and our new Editor-in-Chief will live tweet his answers
Virulence is a fully open access peer-reviewed journal. All articles will (if accepted) be available for anyone to read anywhere, at any time immediately on publication.
Virulence is the first international peer-reviewed journal of its kind to focus exclusively on microbial pathogenicity, the infection process and host-pathogen interactions. To address the new infectious challenges, emerging infectious agents and antimicrobial resistance, there is a clear need for interdisciplinary research. Virulence brings together scientists and clinical researchers working on the 'pathogen,' the 'host' or the 'antimicrobial agents.' As a multi-disciplinary open access journal, all articles are available for anyone to read anywhere, at any time, immediately on publication.
Virulence is particularly interested in receiving manuscripts on
- Microbial pathogenicity–viruses (including HIV), bacteria, fungi, and parasites
- Molecular and biological function of established and novel virulence factors
- Identification, development and study of antimicrobial agents
- Host-pathogen and pathogen-pathogen interactions
- Host response to infection and immune responses to inhibitors, toxins, and other virulence factors
- Mammalian, other vertebrate as well as invertebrate model organisms and hosts
- Clinical trials evaluating all aspects of the infection process
- Research on bio-terrorism agents
- Vaccine development and evaluation
- Diagnosis of infectious diseases
- Infections in resource-limited settings
Current Special Issues
Autophagy in host-pathogen interactions
|Sensing the heat and the host: Virulence determinants of Histoplasma capsulatum||Sinem Beyhan & Anita Sil|
|Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity||Theo N. Kirkland & Joshua Fierer|
|Turning on virulence: Mechanisms that underpin the morphologic transition and pathogenicity of Blastomyces||Joseph A. McBride MD, Gregory M. Gauthier MD & Bruce S. Klein MD|
|Regulatory T cells in paracoccidioidomycosis||Vera L. G. Calich, Ronei L. Mamoni & Flávio V. Loures|
|The capsule of Cryptococcus neoformans||Arturo Casadevall, Carolina Coelho, Radames J. B. Cordero et al.|